<code id='44CC82024D'></code><style id='44CC82024D'></style>
    • <acronym id='44CC82024D'></acronym>
      <center id='44CC82024D'><center id='44CC82024D'><tfoot id='44CC82024D'></tfoot></center><abbr id='44CC82024D'><dir id='44CC82024D'><tfoot id='44CC82024D'></tfoot><noframes id='44CC82024D'>

    • <optgroup id='44CC82024D'><strike id='44CC82024D'><sup id='44CC82024D'></sup></strike><code id='44CC82024D'></code></optgroup>
        1. <b id='44CC82024D'><label id='44CC82024D'><select id='44CC82024D'><dt id='44CC82024D'><span id='44CC82024D'></span></dt></select></label></b><u id='44CC82024D'></u>
          <i id='44CC82024D'><strike id='44CC82024D'><tt id='44CC82024D'><pre id='44CC82024D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:679
          CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

          WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

          Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

          advertisement

          Pharmaceutical groups and patient advocates are increasingly fighting that approach.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Virtual repurposing can help discover new uses for existing drugs
          Virtual repurposing can help discover new uses for existing drugs

          AdobeTheprocessfordiscoveringdrugstendstobebasedonthesamekindofpigeonholingthatdoctorsusetotreatdise

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Drug firms test therapies to halt Alzheimer’s before symptoms arise

          SinceFebruary2022,AstridaSchaefferhasdrivenabout160milesroundtripeveryotherweektoBrighamandWomen’sHo